Log in to search using one of your social media accounts:


Jinarc (tolvaptan) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Jinarc (tolvaptan) is indicated for the treatment of autosomal dominant polycystic kidney disease (ADPKD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news

Related Links:

More News: Pharmaceuticals | Polycystic Kidney Disease | Urology & Nephrology